CoChat

Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice

Rivière, C, Danos, O, Douar, A M · 2006 · Gene Therapy

The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.

Abstract

Adeno-associated viral (AAV) vectors promote long-term gene transfer into muscle in many animal species. Increased expression levels may be obtained by using alternative serotypes in combination with repeated administrations. Here we compared AAV vectors based on serotypes 1, 2 and 5 in immunocompetent mice and assessed the feasibility of multiple administrations of either identical (readministration) or different (cross-administration) serotype-based vectors. A 1-year-long dose-response study confirmed the superiority of recombinant (r)AAV1, achieving transduction levels 5 to 10-fold higher than rAAV2 and rAAV5 in mouse skeletal muscle, respectively. Repeated administration demonstrated that increased gene transfer level was achieved with a second injection of rAAV1 following the first administration of rAAV2 or rAAV5. A readministration study with a vector encoding a different gene allowed the evaluation of gene expression from the second vector only. All three rAAVs were inhibited when the animals were previously exposed to the same serotype. In contrast, no significant change in gene expression from the second vector was observed in cross-administration. A humoral immune response was elicited against the viral capsid for all three serotypes following the initial exposure. Neutralizing antibody (NAB) levels correlated with the vector dose injected. No significant cross-reactivity of NAB from a given serotype toward another was observed in vitro. These data provide the first direct comparative evaluation of re- and cross-administration of rAAV1, rAAV2 and rAAV5 in muscle, and further indicate that rAAV1 is capable of transducing muscle tissue when cross-administered.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.gt.3302766

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 54 references

Cited by

See all 192

Metadata

Authors
Rivière, C., Danos, O., & Douar, A. M.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
Douar, A M
Venue
Gene Therapy
Published
2006-05-11
Volume
13
Issue
17
Pages
1300-1308
ISSN
  • 0969-7128 (ISSN-L)
  • 1476-5462
OpenAlex
W2078035839
Cited by
192
References
55
Citations by year
2026: 4 · 2025: 7 · 2024: 17 · 2023: 6 · 2022: 15 · 2021: 9 · 2020: 4 · 2019: 6 · 2018: 5 · 2017: 8 · 2016: 5 · 2015: 7 · 2014: 6 · 2013: 12 · 2012: 15
FWCI
8.89
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Gene Therapy (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
Keywords
adeno-associated virus vectors, AAV1, AAV2, AAV5, serotype comparison, repeated administration, skeletal muscle gene transfer, long-term gene expression, humoral immune response, neutralizing antibodies, dose-response relationship
MeSH terms
Dependovirus, Alkaline Phosphatase, Animals, Antibody Formation, Female, Genetic Vectors, HeLa Cells, Humans, Injections, Intramuscular, Luciferases, Mice, Inbred BALB C, Parvoviridae Infections, Serotyping, Time Factors, Transduction, Genetic, Genetic Therapy, Gene Expression, Muscle, Skeletal, Transgenes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice. https://app.cochat.ai/papers/10.1038/sj.gt.3302766
The paper
Rivière, C., Danos, O., & Douar, A. M. (2006). Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice. Gene Therapy. https://doi.org/10.1038/sj.gt.3302766

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.